Location History:
- Kensington, MA (US) (2011)
- Kensington, MD (US) (2008 - 2022)
Company Filing History:
Years Active: 2008-2022
Title: Mark A. Hoon: Innovator in Pruritus Treatment and Molecular Inhibition
Introduction
Mark A. Hoon, based in Kensington, MD, is a prominent inventor recognized for his significant contributions to the field of pharmaceutical compositions and treatment methods. With a remarkable portfolio of 23 patents, Hoon has dedicated his research and innovation to enhancing health outcomes, particularly in the management of pruritus.
Latest Patents
Among his latest inventions, Hoon has developed compositions and methods for the inhibition of pruritus. One of his notable patents discloses pharmaceutical compositions that comprise a molecular inhibitor of Npr1, which are pivotal in treating, reducing, or preventing both acute and chronic pruritus in mammals. Another significant invention focuses on methods for treating or preventing pruritis by blocking natriuretic polypeptide B (Nppb). This patent outlines the use of Nppb blocking agents administered in effective amounts to alleviate pruritis, alongside a promising in vitro method for identifying compounds that inhibit Nppb activity.
Career Highlights
Mark A. Hoon's career includes noteworthy associations with esteemed institutions such as the University of California and the United States of America as represented by the Department of Health and Human Services. His academic and professional journey is marked by an unwavering commitment to advancing pharmaceutical science and improving therapeutic strategies.
Collaborations
Throughout his career, Hoon has collaborated with respected colleagues in the field, including Charles S. Zuker and Jon Elliot Adler. These partnerships have fostered innovative research and laid the groundwork for advancements in the treatment of pruritus and related conditions.
Conclusion
Mark A. Hoon stands as a distinguished inventor whose work has made significant strides in the medical field. His innovative patents and collaborations reflect a dedication to addressing challenging health issues, particularly in the domain of pruritus treatment. As his career progresses, Hoon’s contributions are sure to leave a lasting impact on pharmaceutical sciences and patient care.